Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study-Reference-Cited by-同舟云学术

Comparison of efficacy and safety of entecavir and switching from entecavir to tenofovir alafenamide fumarate in chronic hepatitis B: Long‐term effects from a prospective study

Published:2021-05-07 Issue:7 Volume:51 Page:767-774
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatology Research

Author:

Hagiwara Satoru¹^ORCID,Nishida Naoshi¹,Ueshima Kazuomi¹,Yoshida Akihiro¹,Minami Yasunori¹,Kudo Masatoshi¹

Affiliation:

1. Department of Gastroenterology and Hepatology Kindai University Faculty of Medicine Osaka‐Sayama Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.13650

Reference26 articles.

1. Quantitative Levels of Hepatitis B Virus DNA and Surface Antigen and the Risk of Hepatocellular Carcinoma in Patients with Hepatitis B Receiving Long-Term Nucleos(t)ide Analogue Therapy

2. Long-Term Outcome after Hepatitis B Surface Antigen Seroclearance in Patients with Chronic Hepatitis B

3. Countermeasures against viral hepatitis B and C in Japan: An epidemiological point of view

4. AASLD guidelines for treatment of chronic hepatitis B

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of preS1 Evaluation in the Management of Chronic Hepatitis B Virus Infection;Medicina;2024-08-16

2. Switching from entecavir to tenofovir alafenamide for maintaining complete virological response in chronic hepatitis B;JGH Open;2023-07-21

3. Effect of fatty liver and fibrosis on hepatocellular carcinoma development in patients with chronic hepatitis B who received nucleic acid analog therapy;Journal of Viral Hepatitis;2023-01-24

4. Switching to tenofovir alafenamide versus continued therapy in chronic hepatitis B patients who were treated with entecavir: A prospective, multicenter, randomized controlled study;Medicine;2022-09-30

5. Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study;Alimentary Pharmacology & Therapeutics;2022-06-23